{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T05:16:32Z","timestamp":1695791792551},"reference-count":25,"publisher":"Wiley","issue":"s4","license":[{"start":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T00:00:00Z","timestamp":1124064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetic Medicine"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1111\/j.1464-5491.2005.1761h.x","type":"journal-article","created":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T15:14:16Z","timestamp":1124118856000},"page":"23-26","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["New options for drug treatment of obesity in patients with Type 2 diabetes"],"prefix":"10.1111","volume":"22","author":[{"given":"R. L.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Y. H.","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,15]]},"reference":[{"key":"e_1_2_11_1_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-7-200504050-00012"},{"key":"e_1_2_11_1_3_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson Jarl S","year":"2004","journal-title":"Diabetes Care"},{"key":"e_1_2_11_1_4_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2337\/diacare.27.1.33","article-title":"Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes","volume":"27","author":"Kelley David E","year":"2004","journal-title":"Diabetes Care"},{"key":"e_1_2_11_1_5_2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archinte.164.9.994","article-title":"The efficacy and safety of sibutramine for weight loss: a systematic review","volume":"164","author":"Arterburn David E","year":"2004","journal-title":"Arch Intern Med"},{"key":"e_1_2_11_1_6_2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/oby.2003.152","article-title":"Effect of sibutramine on weight loss and blood pressure: a meta\u2010analysis of controlled trials","volume":"11","author":"Kim Su H","year":"2003","journal-title":"Obes Res"},{"key":"e_1_2_11_1_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.4.942"},{"key":"e_1_2_11_1_8_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/diacare.26.1.125","article-title":"A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin","volume":"26","author":"McNulty Steven J","year":"2003","journal-title":"Diabetes Care"},{"key":"e_1_2_11_1_9_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X38132"},{"key":"e_1_2_11_1_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17725"},{"key":"e_1_2_11_1_11_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.4.908"},{"key":"e_1_2_11_1_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802847"},{"key":"e_1_2_11_1_13_2","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB(1) receptors stimulates fatty acid synthesis and contributes to diet\u2010induced obesity","volume":"115","author":"Osei Hyiaman D","year":"2005","journal-title":"J Clin Invest"},{"key":"e_1_2_11_1_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00545.2002"},{"key":"e_1_2_11_1_15_2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid\u20101 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1\u2010year experience from the RIO\u2010Europe study","volume":"365","author":"Van Gaal Luc F","year":"2005","journal-title":"Lancet"},{"key":"e_1_2_11_1_16_2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid\u2010based drugs as anti\u2010inflammatory therapeutics","volume":"5","author":"Klein Thomas W","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"e_1_2_11_1_17_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ajcn\/64.3.267","article-title":"A double\u2010blind, placebo\u2010controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge\u2010eating disorder","volume":"64","author":"Greeno CG","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_11_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.142"},{"key":"e_1_2_11_1_19_2","doi-asserted-by":"crossref","first-page":"E617","DOI":"10.1152\/ajpendo.00437.2004","article-title":"Topiramate is an insulin\u2010sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats","volume":"288","author":"Wilkes Jason J","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"e_1_2_11_1_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2004.163"},{"key":"e_1_2_11_1_21_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2004-826178","article-title":"GLP\u20101 receptor agonists and DPP\u20104 inhibitors in the treatment of type 2 diabetes","volume":"36","author":"Ahr\u00e9n B","year":"2004","journal-title":"Horm Metab Res"},{"key":"e_1_2_11_2_2_1","first-page":"1469","article-title":"Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus","volume":"1","author":"Norris SL","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_2_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.9.2505"},{"key":"e_1_2_11_2_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.6.1311"},{"key":"e_1_2_11_2_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00024677-200504020-00001"},{"key":"e_1_2_11_2_6_1","first-page":"369","article-title":"The Long\u2010term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group\u2010model health maintenance organization","volume":"10","author":"Porter Julie A","year":"2004","journal-title":"Am J Manag Care"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-5491.2005.1761h.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-5491.2005.1761h.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:03:46Z","timestamp":1695773026000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-5491.2005.1761h.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,15]]},"references-count":25,"journal-issue":{"issue":"s4","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1111\/j.1464-5491.2005.1761h.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-5491.2005.1761h.x","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,15]]},"assertion":[{"value":"2005-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}